Genetic Variants of the NLRP3 Inflammasome Are Associated with Stroke in Patients with Rheumatoid Arthritis

REFERENCES

1. 1.↵
   1. Wolfe F,
   2. Mitchell DM,
   3. Sibley JT,
   4. Fries JF,
   5. Bloch DA,
   6. Williams CA,
   7. et al.

   The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481–94.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Listing J,
   2. Kekow J,
   3. Manger B,
   4. Burmester GR,
   5. Pattloch D,
   6. Zink A,
   7. et al.

   Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximab. Ann Rheum Dis 2015;74:415–21.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Innala L,
   2. Moller B,
   3. Ljung L,
   4. Magnusson S,
   5. Smedby T,
   6. Södergren A,
   7. et al.

   Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther 2011;13:R131.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Book C,
   2. Saxne T,
   3. Jacobsson LT

   . Prediction of mortality in rheumatoid arthritis based on disease activity markers. J Rheumatol 2005;32:430–4.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Westlake SL,
   2. Colebatch AN,
   3. Baird J,
   4. Kiely P,
   5. Quinn M,
   6. Choy E,
   7. et al.

   The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2010;49:295–307.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Westlake SL,
   2. Colebatch AN,
   3. Baird J,
   4. Curzen N,
   5. Kiely P,
   6. Quinn M,
   7. et al.

   Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature review. Rheumatology 2011;50:518–31.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Woollard KJ

   . Immunological aspects of atherosclerosis. Clin Sci 2013;125:221–35.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Kastbom A,
   2. Verma D,
   3. Eriksson P,
   4. Skogh T,
   5. Wingren G,
   6. Söderkvist P

   . Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (The Swedish TIRA project). Rheumatology 2008;47:415–7.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Kastbom A,
   2. Johansson M,
   3. Verma D,
   4. Söderkvist P,
   5. Rantapää-Dahlqvist S

   . CARD8 p.C10X polymorphism is associated with inflammatory activity in early rheumatoid arthritis. Ann Rheum Dis 2010;69:723–6.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Rajamäki K,
    2. Lappalainen J,
    3. Öörni K,
    4. Välimäki E,
    5. Matikainen S,
    6. Kovanen PT,
    7. et al.

    Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS ONE 2010;5:e11765.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Duewell P,
    2. Kono H,
    3. Rayner KJ,
    4. Sirois CM,
    5. Vladimer G,
    6. Bauernfeind FG,
    7. et al.

    NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357–61.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Li X,
    2. Zhang Y,
    3. Xia M,
    4. Gulbins E,
    5. Boini KM,
    6. Li PL

    . Activation of Nlrp3 inflammasomes enhances macrophage lipid-deposition and migration: implication of a novel role of inflammasome in atherogenesis. PLoS ONE 2014;9:e87552.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Strowig T,
    2. Henao-Mejia J,
    3. Elinav E,
    4. Flavell R

    . Inflammasomes in health and disease. Nature 2012;481:278–86.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Sahdo B,
    2. Fransén K,
    3. Asfaw Idosa B,
    4. Eriksson P,
    5. Söderquist B,
    6. Kelly A,
    7. et al.

    Cytokine profile in a cohort of healthy blood donors carrying polymorphisms in genes encoding the NLRP3 inflammasome. PLoS One 2013;8:e75457.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Verma D,
    2. Särndahl E,
    3. Andersson H,
    4. Eriksson P,
    5. Fredrikson M,
    6. Jönsson JI,
    7. et al.

    The Q705K polymorphism in NLRP3 is a gain-of-function alteration leading to excessive interleukin-1β and IL-18 production. PLoS One 2012;7:e34977.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Ito S,
    2. Hara Y,
    3. Kubota T

    . CARD8 is a negative regulator for NLRP3 inflammasome, but mutant NLRP3 in cryopyrin-associated periodic syndromes escapes the restriction. Arthritis Res Ther 2014;16:R52.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Fontalba A,
    2. Martinez-Taboada V,
    3. Gutierrez O,
    4. Pipaon C,
    5. Benito N,
    6. Balsa A,
    7. et al.

    Deficiency of the NF-kappaB inhibitor caspase activating and recruitment domain 8 in patients with rheumatoid arthritis is associated with disease severity. J Immunol 2007;179:4867–73.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Roberts RL,
    2. Van Rij AM,
    3. Phillips LV,
    4. Young S,
    5. McCormick SP,
    6. Merriman TR,
    7. et al.

    Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis 2011;218:123–6.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Schoultz I,
    2. Verma D,
    3. Halfvarsson J,
    4. Törkvist L,
    5. Fredrikson M,
    6. Sjöqvist U,
    7. et al.

    Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn’s disease in Swedish men. Am J Gastroenterol 2009;104:1180–8.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Roberts RL,
    2. Topless RK,
    3. Phipps-Green AJ,
    4. Gearry RB,
    5. Barclay ML,
    6. Merriman TR

    . Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn’s disease. Genes Immun 2010;11:351–6.

    OpenUrlCrossRefPubMed
21. 21.↵
    1. Arnett FC,
    2. Edworthy SM,
    3. Bloch DA,
    4. McShane DJ,
    5. Fries JF,
    6. Cooper NS,
    7. et al.

    The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Ärlestig L,
    2. Rantapää-Dahlqvist S

    . Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease. J Rheumatol 2012;39:939–45.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. Prineas RJ,
    2. Blackburn H

    . The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Boston: John Wright & Son Ltd; 1982.
24. 24.↵
    1. Baecklund E,
    2. Sundström C,
    3. Ekbom A,
    4. Catrina AI,
    5. Biberfeld P,
    6. Feltelius N,
    7. et al.

    Lymphoma subtypes in patients with rheumatoid arthritis: increased proportion of diffuse large B cell lymphoma. Arthritis Rheum 2003;48:1543–50.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Bengtsson C,
    2. Ohman ML,
    3. Nived O,
    4. Rantapää Dahlqvist S

    . Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study. Lupus 2012;21:452–9.

    OpenUrlAbstract/FREE Full Text
26. 26.↵
    1. Berglin E,
    2. Padyukov L,
    3. Sundin U,
    4. Hallmans G,
    5. Stenlund H,
    6. Van Venrooij WJ,
    7. et al.

    A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther 2004;6:R303–8.

    OpenUrlCrossRefPubMed
27. 27.↵
    1. Jashari F,
    2. Ibrahimi P,
    3. Nicoll R,
    4. Bajraktari G,
    5. Wester P,
    6. Henein MY

    . Coronary and carotid atherosclerosis: similarities and differences. Atherosclerosis 2013;227:193–200.

    OpenUrlCrossRefPubMed
28. 28.↵
    1. Farb A,
    2. Burke AP,
    3. Tang AL,
    4. Liang TY,
    5. Mannan P,
    6. Smialek J,
    7. et al.

    Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation 1996;93:1354–63.

    OpenUrlAbstract/FREE Full Text
29. 29.↵
    1. Pryshchep O,
    2. Ma-Krupa W,
    3. Younge BR,
    4. Goronzy JJ,
    5. Weyand CM

    . Vessel-specific Toll-like receptor profiles in human medium and large arteries. Circulation 2008;118:1276–84.

    OpenUrlAbstract/FREE Full Text
30. 30.↵
    1. Fukushima R,
    2. Soejima H,
    3. Fukunaga T,
    4. Nakayama M,
    5. Oe Y,
    6. Oshima S,
    7. et al.

    Expression levels of Toll-like receptor genes in coronary atherosclerotic lesions of patients with acute coronary syndrome or stable angina pectoris. Circ J 2009;73:1479–84.

    OpenUrlCrossRefPubMed
31. 31.↵
    1. Katsargyris A,
    2. Tsiodras S,
    3. Theocharis S,
    4. Giaginis K,
    5. Vasileiou I,
    6. Bakoyiannis C,
    7. et al.

    Toll-like receptor 4 immunohistochemical expression is enhanced in macrophages of symptomatic carotid atherosclerotic plaques. Cerebrovasc Dis 2011;31:29–36.

    OpenUrlCrossRefPubMed
32. 32.↵
    1. Gidlöf O,
    2. Smith JG,
    3. Melander O,
    4. Lövkvist H,
    5. Hedblad B,
    6. Engström G,
    7. et al.

    A common missense variant in the ATP receptor P2X7 is associated with reduced risk of cardiovascular events. PLoS One 2012;7:e37491.

    OpenUrlCrossRefPubMed
33. 33.↵
    1. Varghese GP,
    2. Fransén K,
    3. Hurtig-Wennlöf A,
    4. Bengtsson T,
    5. Jansson JH,
    6. Sirsjö A

    . Q705K variant in gene confers protection against myocardial infarction in female individuals. Biomed Rep 2013;1:879–82.

    OpenUrlPubMed
34. 34.↵
    1. García-Bermúdez M,
    2. López-Mejías R,
    3. González-Juanatey C,
    4. Corrales A,
    5. Castañeda S,
    6. Ortiz AM,
    7. et al.

    CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients. DNA Cell Bio 2013;32:28–33.

    OpenUrlCrossRefPubMed
35. 35.↵
    1. Paramel GV,
    2. Folkersen L,
    3. Strawbridge RJ,
    4. Elmabsout AA,
    5. Särndahl E,
    6. Lundman P,
    7. et al.

    CARD8 gene encoding a protein of innate immunity is expressed in human atherosclerosis and associated with markers of inflammation. Clin Sci 2013;125:401–7.

    OpenUrlCrossRefPubMed
36. 36.↵
    1. Bai Y,
    2. Nie S,
    3. Jiang G,
    4. Zhou Y,
    5. Zhou M,
    6. Zhao Y,
    7. et al.

    Regulation of CARD8 expression by ANRIL and association of CARD8 single nucleotide polymorphism rs2043211 (p.C10X) with ischemic stroke. Stroke 2014;45:383–8.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Yang F,
    2. Wang Z,
    3. Wei X,
    4. Han H,
    5. Meng X,
    6. Zhang Y,
    7. et al.

    NLRP3 deficiency ameliorates neurovascular damage in experimental ischemic stroke. J Cereb Blood Flow Metab 2014;34:660–7.

    OpenUrlCrossRefPubMed
38. 38.↵
    1. Ross J,
    2. Brough D,
    3. Gibson RM,
    4. Loddick SA,
    5. Rothwell NJ

    . A selective, non-peptide caspase-1 inhibitor, VRT-018858, markedly reduces brain damage induced by transient ischemia in the rat. Neuropharmacology 2007;53:638–42.

    OpenUrlCrossRefPubMed
39. 39.↵
    1. Fann DY,
    2. Lee SY,
    3. Manzanero S,
    4. Tang SC,
    5. Gelderblom M,
    6. Chunduri P,
    7. et al.

    Intravenous immunoglobulin suppresses NLRP1 and NLRP3 inflammasome-mediated neuronal death in ischemic stroke. Cell Death Dis 2013;4:e790.

    OpenUrlCrossRefPubMed